相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual-Color Click Beetle Luciferase Heteroprotein Fragment Complementation Assays
Victor Villalobos et al.
CHEMISTRY & BIOLOGY (2010)
Octamer 4 (Oct4) Mediates Chemotherapeutic Drug Resistance in Liver Cancer Cells Through a Potential Oct4-AKT-ATP-Binding Cassette G2 Pathway
Xiao Qi Wang et al.
HEPATOLOGY (2010)
Stem-like Cancer Cells Are Inducible by Increasing Genomic Instability in Cancer Cells
Yi Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Damaged DNA-binding Protein 1 (DDB1) Interacts with Cdh1 and Modulates the Function of APC/CCdh1
Xiao-Bin Lv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Glycogen synthase kinase 3 beta: can it be a target for oral cancer
Rajakishore Mishra
MOLECULAR CANCER (2010)
Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
Hsiangling Teo et al.
NATURE CELL BIOLOGY (2010)
GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer
Aaron C. Spalding
NEOPLASIA (2010)
α1-Adrenergic Receptor Stimulates Interleukin-6 Expression and Secretion through Both mRNA Stability and Transcriptional Regulation: Involvement of p38 Mitogen-Activated Protein Kinase and Nuclear Factor-κB
Dianne M. Perez et al.
MOLECULAR PHARMACOLOGY (2009)
Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases
Chang-ye Zou et al.
ACTA PHARMACOLOGICA SINICA (2008)
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
Satish Patel et al.
CANCER CELL (2008)
GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers
Tiebang Kang et al.
CANCER CELL (2008)
Maintenance of constitutive IκB kinase activity by glycogen synthase kinase-3α/β in pancreatic cancer
Willie Wilson et al.
CANCER RESEARCH (2008)
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation
Svetlana Kotliarova et al.
CANCER RESEARCH (2008)
Current concepts on the surgical and medical management of osteosarcoma
Herrick J. Siegel et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Targeting the nuclear factor-κB rescue pathway has promising future in human renal cell carcinoma therapy
Carole Sourbier et al.
CANCER RESEARCH (2007)
NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation
S. J. Van Laere et al.
BRITISH JOURNAL OF CANCER (2007)
Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines
Jun-qiang Yin et al.
ACTA PHARMACOLOGICA SINICA (2007)
Parthenolide, a natural inhibitor of nuclear factor-kappa B, inhibits lung colonization of murine osteosarcoma cells
Yuki Kishida et al.
CLINICAL CANCER RESEARCH (2007)
Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NF kappa B
RA Eliseev et al.
EXPERIMENTAL CELL RESEARCH (2006)
Nuclear factor-kappa B signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappa B DNA-binding
Steven J. Van Laere et al.
CLINICAL CANCER RESEARCH (2006)
Increased radiation-induced apoptosis of Saos2 cells via inhibition of NFKB: A role for c-Jun N-terminal kinase
RA Eliseev et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-α
M Eto et al.
CIRCULATION (2005)
Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-κB activity:: Role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively
MI Vega et al.
JOURNAL OF IMMUNOLOGY (2005)
Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo
E Jimi et al.
NATURE MEDICINE (2004)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
β-catenin interacts with and inhibits NF-κB in human colon and breast cancer
JO Deng et al.
CANCER CELL (2002)
Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents
M Sheehan et al.
MOLECULAR PHARMACOLOGY (2002)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
NF-κB signaling pathways in mammalian and insect innate immunity
N Silverman et al.
GENES & DEVELOPMENT (2001)
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich et al.
NATURE (2000)
分享论文
